Over the past 20 years, we have established long-term collaborations with some of the largest pharmaceutical companies worldwide and built strong relationships with numerous smaller pharmaceutical and biotechnology companies.
Our success lies on the varied backgrounds and substantial breadth and depth of experience of our senior consultants. They have contributed to the development and successful commercialization of 13 products for major therapeutic areas by solving problems and by providing strategic advice and operational support for an effective communication of product attributes and benefits. A number of biopharmaceutical enterprises have taken advantage of their medical and regulatory experience to make decisions at critical points of the development process. Investors and start-ups have profited from their scientific knowledge and expertise to boost the translation of new research outcomes into innovative and marketable applications for the benefit of patients.
Our fast reaction to changes in the regulatory and competitive environment and our ability to deliver on promises with measurable impact and results have also contributed to set us apart from our competitors.
Today, Avail Pharma has gained a consolidated international recognition and our business is tangibly successful on a global scale.